Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...

The novel, as a form, for a long time, has been concerned with the representation of consciousness. From the intricate psychological portraits of Henry James to the stream-of-consciousness experiments ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

As of September 19, 2025, Recursion Pharmaceuticals, Inc. had a $2.1 billion market capitalization, putting it in the 57th percentile of companies in the Biotechnology industry. Recursion ...

A syntax checker was designed based on the syntax of ALGOL as described in the ALGOL 60 Report [Communications of the ACM, May 1960]. Since the definition of the elements of the language is recursive ...